Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 401–500 of 999
Morbidity But Not Mortality Is Decreased After Off-Pump Coronary Artery Bypass Surgery
Brewer, R. J., Theurer, P. F., Cogan, C. M., Bell, G. F., Prager, R. L., & Paone, G. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.08.062 · Cited by 28
Roffi, M., Patrono, C., Collet, J., Mueller, C. E., Valgimigli, M., Bax, J. J., Borger, M. A., Chew, D. P., Hasenfuss, G. P., Kjeldsen, K. P., et al. (2015) · Cited by 27
Damluji, A. A., Nanna, M. G., Mason, P., Lowenstern, A. M., Orkaby, A. R., Washam, J. B., Kolkailah, A. A., Beckie, T. M., Dangas, G., & Lawton, J. S. (2025) · Circulation · doi:10.1161/cir.0000000000001387 · Cited by 34
Self-citationBuszman, P. E., Buszman, P. P., Bochenek, A. A., Gierlotka, M. J., Gąsior, M., Milewski, K. P., Orlik, B., Janas, A. J., Wojakowski, W., Kiesz, R. S., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.008 · Cited by 27
Fanari, Z., Weiss, S. A., Zhang, W., Sonnad, S. S., & Weintraub, W. S. (2015) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2015.01.002 · Cited by 29
“On the other hand, in the FREEDOM trial PCI was associated with higher incidence of death and MI with a lower incidence of stroke when compared to CABG [12].”
BackgroundMethodResultInfluentialWang, T. K. M., Woodhead, A., Ramanathan, T., & Pemberton, J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.05.117 · Cited by 32
“Coronary artery bypass grafting was found in most [3,4] but not all [5,6] randomised trials to be superior to percutaneous coronary intervention for multivessel coronary artery disease, particularly those with moderate or high Syntax score >22, and is recommended by guidelines in this context [7].”
BackgroundCost and Outcome of Minimally Invasive Techniques for Coronary Surgery Using Robotic Technology
Pasrija, C., Kon, Z. N., Ghoreishi, M., Lehr, E. J., Gammie, J. S., Griffith, B. P., Bonatti, J. O., & Taylor, B. S. (2018) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1097/imi.0000000000000537 · Cited by 27
Wolfe, N. K., Mitchell, J. D., & Brown, D. L. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa032 · Cited by 27
“No information on medication use and successful risk factor modification was reported, although it recommended providers follow guideline-driven goals for risk factor reduction including target low-density lipoprotein cholesterol level of <70 mg per decilitre, blood pressure <130/80 mmHg, and glycated haemoglobin <7%.…”
BackgroundCollet, J., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J. K., Bhatt, D. L., Dendale, P., Dorobanţu, M., Edvardsen, T., Folliguet, T. A., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.12.024 · Cited by 46
Reith, S., Battermann, S., Hellmich, M., Marx, N., & Burgmaier, M. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0633-7 · Cited by 29
“Given that our data revealed a greater LL in patients with diabetes compared to non-diabetics, it is tempting to speculate that longer LL may have contributed to the negative clinical outcome with PCI in these trials [37, 39].”
ResultImpact of Perioperative Glycemic Control Strategy on Patient Survival After Coronary Bypass Surgery
Pezzella, A. T., Holmes, S. D., Pritchard, G., Speir, A. M., & Ad, N. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.05.067 · Cited by 31
Farkouh, M. E., Godoy, L. C., Brooks, M. M., Mancini, G. B. J., Vlachos, H. A., Bittner, V., CHAITMAN, B. R., Siami, F. S., Hartigan, P. M., Frye, R. L., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.536 · Cited by 30
Self-citationVascular Complications of Diabetes Mellitus
Chiong, Y., & Evans‐Molina, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-37078-6_49 · Cited by 31
Basman, C. L., Hemli, J. M., Kim, M. C., Seetharam, K., Brinster, D. R., Pirelli, L., Kliger, C., Scheinerman, S. J., Singh, V. P., & Patel, N. C. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14891 · Cited by 25
“Consequently, we sought to evaluate the 8‐year survival data after HCR for TVD, and we compared it with that of concurrent matched patients who had either traditional CABG via sternotomy or multivessel PCI.”
BackgroundResultInfluentialPei, J., Wang, X., Xing, Z., Zheng, K., & Hu, X. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13141 · Cited by 29
“5%) patients with LVEF <30%.(33) High-quality evidence from randomized controlled studies for revascularization strategies for patients with severely reduced LVEF is insufficient.”
BackgroundMatsumura‐Nakano, Y., Shiomi, H., Morimoto, T., Yamaji, K., Ehara, N., Sakamoto, H., Takeji, Y., Yoshikawa, Y., Yamamoto, K., Imada, K., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.076 · Cited by 27
Incidence and predictors of postoperative ischemic stroke after coronary artery bypass grafting
Mohamed, M., Hirji, S. A., Mohamed, W. A., Percy, E., Braidley, P. C., Chung, J. S., Aranki, S. F., & Mamas, M. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14067 · Cited by 27
Gaudino, M., Franco, A. D., Spadaccio, C., Rahouma, M., Robinson, N., Demetres, M., Fremes, S., & Doenst, T. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.062 · Cited by 21
Sanz, J., Moreno, P., & Fuster, V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.045 · Cited by 43
Self-citationHerbison, P., & Wong, C.-K. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-010055 · Cited by 26
Ariyaratne, T. V., Yap, C., Ademi, Z., Rosenfeldt, F., Duffy, S. J., Billah, B., & Reid, C. M. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw007 · Cited by 29
“Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents
von Birgelen, C., Kok, M. M., Sattar, N. A., Zocca, P., Doelman, C. J. A., Kant, G. D., Löwik, M. M., van der Heijden, L. C., Sen, H., van Houwelingen, K. G., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.10.038 · Cited by 31
Hybrid coronary revascularization for the treatment of multivessel coronary artery disease
Kayatta, M. O., Halkos, M. E., & Puskas, J. D. (2018) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2018.06.09 · Cited by 26
“com While multiple clinical trials have demonstrated superior freedom from angina and revascularization with CABG over isolated PCI (1-3), it is not clear whether this benefit comes from the LIMA-LAD alone, which has a 10–15-year patency of greater than 95% (4), or whether SVG also contribute to this, since they have…”
BackgroundPrognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery
Santos, K. A. Q., Berto, B., de Sousa, A. G., & da Costa, F. A. A. (2015) · Brazilian Journal of Cardiovascular Surgery · doi:10.5935/1678-9741.20160002 · Cited by 27
“([3])Descriptive level of probability determined by the nonparametric Mann-Whitney U test.”
BackgroundMethodInfluentialJeong, Y., Ahn, J., Hyun, J., Lee, J., Kim, J. H., Yang, Y., Choe, K., Park, H., Kang, D., Lee, P. H., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019834 · Cited by 27
“7,16 As a result, DM has been regarded as a key determinant for predicting poor prognosis and selecting optimal myocardial revascularization among several clinical risk factors.”
Temporal Trends in Complex Percutaneous Coronary Interventions
Kheifets, M., Vons, S. A., Bental, T., Assa, H. V., Greenberg, G., Samara, A., Codner, P., Witberg, G., Talmor‐Barkan, Y., Perl, L., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.913588 · Cited by 25
“Despite the FREEDOM (18) trial which demonstrated CABG superiority over PCI for Frontiers in Cardiovascular Medicine | www.frontiersin.org 7 June 2022 | Volume 9 | Article 913588 patients with multivessel CAD and DM, the total amount of PCIs is on the rise with a parallel decline in CABG (19).”
BackgroundBrovman, E. Y., Gabriel, R. A., Lekowski, R. W., Dutton, R. P., & Urman, R. D. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.08.006 · Cited by 25
Kang, S. H., Ahn, J., Lee, C. H., Lee, P. H., Kang, S., Lee, S., Kim, Y., Lee, C. W., Park, S., Park, D., et al. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004988 · Cited by 25
Savonitto, S., Morici, N., Nozza, A., Cosentino, F., Filardi, P. P., Murena, E., Morocutti, G., Ferri, M., Cavallini, C., Eijkemans, M. J. C., et al. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117735493 · Cited by 26
“Despite clear evidence that bypass surgery should be the preferred revascularization modality among patients with diabetes, 39 percutaneous coronary intervention is prominent among ACS patients, particularly in the case of ST segment elevation myocardial infarction (STEMI).”
Initiation and modification of minimally invasive coronary artery bypass grafting
Une, D., & Sakaguchi, T. (2018) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-018-1050-7 · Cited by 25
Myocardial dysfunction and cardiovascular disease in type 2 diabetes
Ofstad, A. P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2016.1155230 · Cited by 25
“In addition, in the setting of advanced CAD and diabetes it seems that PCI is inferior to coronary artery bypass grafting (CABG) in preventing death and re-infarction [53].”
BackgroundConcerns with the new SYNTAX score – Authors' reply
Takahashi, K., Klaveren, D. V., Steyerberg, E. W., Onuma, Y., & Serruys, P. W. J. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00195-1 · Cited by 25
MacDonald, M. R., She, L., Doenst, T., Binkley, P. F., Rouleau, J. L., Tan, R.-S., Lee, K. L., Miller, A. B., Sopko, G., Szalewska, D., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.288 · Cited by 24
Coronary Artery Surgery: Past, Present, and Future
Ghandakly, E., Iacona, G. M., & Bakaeen, F. G. (2024) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10515 · Cited by 24
Tatoulis, J., Wynne, R. M., Skillington, P. D., & Buxton, B. F. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.05.062 · Cited by 24
Noman, A., Balasubramaniam, K., Alhous, M. H. A., Lee, K., Jesudason, P., Rashid, M. O., Mamas, M. A., & Zaman, A. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26882 · Cited by 27
Burgess, S. N., French, J. K., Nguyen, T. L., Leung, M., Richards, D. A. B., Thomas, L., Mussap, C., Lo, S. T., & Juergens, C. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.07.017 · Cited by 24
“001 Cardiac death 1% (2) 3% (8) 12% (23) .”
Zhou, P., Zhu, P., Nie, Z., & Zheng, S. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.01.129 · Cited by 26
Yu, L., Zhu, K., Du, N., Si, Y.-X., Liang, J., Shen, R., & Chen, B. (2022) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-022-01903-w · Cited by 24
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients
Nardin, M., Verdoia, M., Sartori, C., Pergolini, P., Rolla, R., Barbieri, L., Schaffer, A., Bellomo, G., Suryapranata, H., & Luca, G. D. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.04.021 · Cited by 25
Cardiac surgery or interventional cardiology? Why not both? Let's go hybrid
Papakonstantinou, N. A., Baikoussis, N. G., Dedeilias, P., Argiriou, M. E., & Charitos, C. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.09.007 · Cited by 31
Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?
Marcinkiewicz, A. M., Ostrowski, S., & Drzewoski, J. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0219-z · Cited by 27
“Nevertheless, FREEDOM trial [33] proved that allcause mortality and myocardial infarction rate were significantly lower in the case of surgical revascularization, despite preserved current pharmacological regimens and drug eluting stents (DES) usage.”
BackgroundShould Diabetes Be a Contraindication to Bilateral Internal Mammary Artery Grafting?
Iribarne, A., Westbrook, B. M., Malenka, D. J., Schmoker, J. D., McCullough, J. N., Leavitt, B. J., Weldner, P. W., DeSimone, J. P., Kramer, R. S., Quinn, R. D., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.08.054 · Cited by 24
Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Lee, S., Hong, S., Shin, D., Kim, J., Ko, Y., Choi, D., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6841-7 · Cited by 24
Urgent Revascularization Strategies in Patients With Diabetes Mellitus and Acute Coronary Syndrome
Godoy, L. C., Lawler, P. R., Farkouh, M. E., Hersen, B., Nicolau, J. C., & Rao, V. A. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.03.010 · Cited by 28
Self-citationThe coronary collateral circulation—clinical relevances and therapeutic options
Meier, P., & Seiler, C. A. (2012) · Heart · doi:10.1136/heartjnl-2012-303426 · Cited by 24
Diseases of the Cardiovascular System
Lockhart, P. B., & Sun, Y. (2021) · Wiley eBooks · doi:10.1002/9781119597797.ch14 · Cited by 32
Development of tissue-engineered vascular grafts from decellularized parsley stems
Cevik, M., & Dıkıcı, S. (2023) · Soft Matter · doi:10.1039/d3sm01236k · Cited by 26
Long-term results after robotically assisted coronary bypass surgery
Bonatti, J. O., Ramahi, J., Hasan, F., Edris, A., Bartel, T., Nair, R., Tuzcu, M., Suri, R. M., & Mihaljević, T. (2016) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2016.11.04 · Cited by 23
Effect of Diabetes Mellitus on Complication Rates of Coronary Artery Bypass Grafting
Brush, J. E., Siraj, E. S., Kemp, C. D., Liverman, D. P., McMichael, B. Y., Lamichhane, R., & Sheehan, B. E. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.053 · Cited by 23
Dhurandhar, V., Saxena, A., Parikh, R. N., Vallely, M. P., Wilson, M. K., Butcher, J. K., Black, D. A., Tran, L., Reid, C. M., & Bannon, P. G. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.04.162 · Cited by 23
“Moreover, trial data have demonstrated superiority to percutaneous coronary intervention (PCI) in many clinical settings [5–7].”
BackgroundChew, N., Koh, J. H., Ng, C., Tan, D., Yong, J. N., Lin, C.-X., Lim, O., Chin, Y. H., Lim, D. M. W., Chan, K., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.822228 · Cited by 22
“The lower mortality with CABG compared to PCI is consistent with the SYNTAX trial that used first-generation (8) and the BEST trial that used second-generation DES (6).”
MethodResultInfluentialWollmuth, J. R., Patel, M. P., Dahle, T. G. A., Bharadwaj, A. S., Waggoner, T. E., Chambers, J. W., Ruiz‐Rodriguez, E., Mahmud, E., Thompson, C. A., & Morris, D. L. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100350 · Cited by 34
Lima, E. G., Hueb, W. A., Gersh, B. J., Rezende, P. C., Garzillo, C. L., Favarato, D., Hueb, A. C., Garcia, R. M. R., Ramires, J. A. F., & Filho, R. K. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.10.036 · Cited by 25
“More recent published trials designed to compare treatment strategies for CAD in diabetic subjects, such as BARI-2D [22] and FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease) trial [23], did not assess the effects of renal function on the perfor…”
MethodSelf-citationCosta, F., Ariotti, S., Valgimigli, M., Kolh, P. H., & Windecker, S. (2015) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-015-9632-6 · Cited by 25
“These recommendations are mainly based on the results of the FREEDOM trial [15]; this study randomized diabetic patients with multivessel disease to CABG or PCI+DES and found a significantly higher rate of the primary endpoint—a composite of death, myocardial infarction, and stroke—in the PCI group.”
BackgroundMethodKurlansky, P. A., Herbert, M. A., Prince, S. L., & Mack, M. J. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw375 · Cited by 23
Self-citationShah, S., Benedetto, U., Caputo, M., Angelini, G. D., & Vohra, H. A. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy236 · Cited by 28
“7% CABG patients in the trial had poor LVF [11].”
BackgroundThe Eternal Debate With a Consistent Answer: CABG vs PCI
Farina, P., Gaudino, M. F. L., & Taggart, D. P. (2019) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2019.08.009 · Cited by 28
Doenst, T., & Sigusch, H. H. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.10.121 · Cited by 24
Five years after the SYNTAX trial: what have we learnt?
Davierwala, P. M., & Mohr, F. W. (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt267 · Cited by 23
Klempfner, R., Elis, A., Matezky, S., Keren, G., Roth, A., Finkelstein, A., Banai, S., Goldenberg, I., Fisman, E. Z., Tenenbaum, A., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.116 · Cited by 24
Costopoulos, C., Latib, A., Naganuma, T., Sticchi, A., Chieffo, A., Figini, F., Carlino, M., Montorfano, M., Naim, C., Kawaguchi, M., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.033 · Cited by 22
Haiek, C., Fernández‐Pereira, C., Santaera, O., Mieres, J., Rifourcat, I., Lloberas, J., Larribau, M., Pocoví, A., Rodriguez-Granillo, A. M., Sarmiento, R. A., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26468 · Cited by 22
Cardiovascular disease in chronic kidney disease in 2015
Sud, M. K., & Naimark, D. M. J. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000213 · Cited by 23
Rados, D. R. V., Pinto, L. C. F., Leitão, C. B., & Gross, J. L. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015089 · Cited by 23
Li, Y., Dong, R., Hua, K., Liu, T.-S., Zhou, S., Zhou, N., & Zhang, H. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.220305 · Cited by 23
“03) at 5 years.[7] The Arterial Revascularization Therapy Study II trial has demonstrated that CABG therapy reduced the incidence of repeat revascularization and overall MACCE, but it did not influence the hard end points, such as death and MI, compared to treatment with SES.”
MethodResultDing, T., Yuan, X., Chen, K., Shen, L., Guan, C., Lv, F., Xiong, H., Xu, B., Wu, Y., & Hu, S. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.09.049 · Cited by 22
Complex and high-risk intervention in indicated patients (CHIP) in contemporary clinical practice
Fujimoto, Y., Sakakura, K., & Fujita, H. (2023) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-023-00930-1 · Cited by 23
“Although randomized controlled trials have shown favorable outcomes with CABG compared with PCI in patients with an intermediate to high Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score [15, 16], patients who were considered inoperable or at higher risk for CABG were exc…”
Contemporary Coronary Artery Bypass Grafting vs Multivessel Percutaneous Coronary Intervention
Mehaffey, J. H., Hayanga, J. W. A., Kawsara, M. A., Sakhuja, A., Mascio, C. E., Rankin, J. S., & Badhwar, V. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2023.05.032 · Cited by 22
Self-citationOne-year clinical and angiographic results of hybrid coronary revascularization
Modrau, I. S., Holm, N. R., Mæng, M., Bøtker, H. E., Christiansen, E. H., Kristensen, S. D., Lassen, J. F., Thuesen, L., & Nielsen, P. H. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.08.072 · Cited by 22
“Well-powered randomized studies, and large-scale registries in patients with stable multivessel disease, have documented the superiority of CABG compared with PCI, taking into consideration repeat revascularization, myocardial infarction, and death, whereas early stroke rates were increased after surgical revasculariz…”
MethodRobotic CABG and Hybrid Approaches: The Current Landscape
Ejiofor, J. I., Leacche, M., & Byrne, J. G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.012 · Cited by 23
Ariyaratne, T. V., Ademi, Z., Yap, C., Billah, B., Rosenfeldt, F., Yan, B. P., & Reid, C. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.072 · Cited by 22
“Moreover, the FREEDOM trial [11] may have unfairly influenced our pooled analyses due to robustness of the data included.”
MethodResultGeorge, I., Nazif, T. M., Kalesan, B., Kriegel, J. M., Yerebakan, H., Kirtane, A. J., Kodali, S., & Williams, M. R. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.01.028 · Cited by 22
“However, the SYNTAX trial also clearly demonstrates a survival benefit of CABG for patients with a higher burden of disease, as reflected by a high SYNTAX score (greater than 33), and in specific patient subsets, such as patients with diabetes mellitus [10, 11].”
BackgroundCoronary Revascularization in the Diabetic Patient
Silvain, J., Vignalou, J.-B., Barthélémy, O., Kernéis, M., Collet, J., & Montalescot, G. (2014) · Circulation · doi:10.1161/circulationaha.113.004382 · Cited by 22
Lautamäki, A., Kiviniemi, T., Biancari, F., Airaksinen, J. K. E., Juvonen, T. S., & Gunn, J. M. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv233 · Cited by 22
Kennedy, M., Hermanides, R. S., Kaplan, E., Hemradj, V. V., Fabris, E., Koopmans, P. C., Dambrink, J. E., Gosselink, A. T. M., Hof, A. W. J. V. ’., Ottervanger, J. P., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.059 · Cited by 22
ABC investigators, Asakura, M., Kim, J., Asanuma, H., Hamasaki, T., Tsukahara, K., Higashino, Y., Ishikawa, T., Nakama, Y., Koba, S., et al. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6740-3 · Cited by 23
“In an IGT population with a previous MI, there was no significant difference in the prevalence of revascularization between oral medical alpha-glucose therapy and diet/exercise therapy [23, 24].”
BackgroundOff-Pump Versus On-Pump Impact: Diabetic Patient 5-Year Coronary Artery Bypass Clinical Outcomes
Shroyer, A. L., Quin, J. A., Wagner, T. H., Carr, B. M., Collins, J. F., Almassi, G. H., Bishawi, M. M., Grover, F. L., & Hattler, B. G. J. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.07.076 · Cited by 22
Revascularization Options for Females With Multivessel Coronary Artery Disease
Gül, B., Shah, T., Head, S. J., Chieffo, A., Hu, X. Y., Li, F., Brackett, A. L., Gesick, C., Bisarya, P. K., & Lansky, A. J. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.12.036 · Cited by 22
Self-citationLong-term outcomes after coronary artery bypass surgery in patients with diabetes
Axelsson, T. A., Aðalsteinsson, J. A., Árnadóttir, L. Ó., Helgason, D., Jóhannesdóttir, H., Helgadóttir, S., Orrason, A. W., Andersen, K. K., & Guðbjartsson, T. (2020) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivaa009 · Cited by 28
Azzarelli, S. A., Boukhris, M., Giubilato, S., Tomasello, S. D., Castaing, M., Giunta, R., Marzà, F., Abdelbasset, H. M., Khamis, H., & Galassi, A. R. (2015) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2015.07.003 · Cited by 21
“Furthermore, in high risk patients such as diabetics, clear evidence has been demonstrated in favor of CABG, in the setting of multivessel disease [22].”
BackgroundTu, B., Rich, B., Labos, C., & Brophy, J. M. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0808 · Cited by 23
Campos, C. M., Christiansen, E. H., Stone, G. W., & Serruys, P. W. J. C. (2015) · EuroIntervention · doi:10.4244/eijv11sva26 · Cited by 21
Nielsen, S. J., Bjorck, L. M., Jeppsson, A., Giang, K. W., Falk, K., Määttä, S., Sandström, T. Z., & Rosengren, A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.013 · Cited by 21
Multivessel Coronary Artery Disease
Bryer, E. J., Stein, E., & Goldberg, S. (2020) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.07.014 · Cited by 21
Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation
Dokollari, A., Sicouri, S., Erten, O., Gray, W. A., Shapiro, T. A., McGeehin, F. C., Badri, M., Coady, P. M., Gnall, E., Caroline, M., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-23-00373 · Cited by 21
Chou, C., Hsieh, T., Wang, C., Hung, T., Lai, Y., Chen, Y.-Y., Lin, Y., Kuo, C., Wu, Y.-J., & Fang, T. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.01.009 · Cited by 21
Osnabrugge, R. L. J., Magnuson, E. A., Serruys, P. W. J. C., Campos, C. M., Wang, K., Klaveren, D. V., Farooq, V., Abdallah, M., Li, H., Vilain, K. R., et al. (2015) · Heart · doi:10.1136/heartjnl-2015-307578 · Cited by 21
Self-citationJiménez-Navarro, M. F., López-Jiménez, F., Barsness, G., Lennon, R. J., Sandhu, G. S., & Prasad, A. (2015) · Heart · doi:10.1136/heartjnl-2014-307143 · Cited by 21
Krishnaswami, A., McCulloch, C. E., Tawadrous, M., Jang, J. J., Lee, H., Melikian, V., Yee, G., Leong, T. K., & Go, A. S. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv104 · Cited by 21
“Although it will not directly deliver a comparative effectiveness answer between CABG and PCI such as the FREEDOM [22] study brought to diabetics, it will shed some light into these muddy waters.”
BackgroundKalkman, D. N., Woudstra, P., den Heijer, P., Menown, I. B. A., Ērglis, A., Suryapranata, H., Arkenbout, K., Íñiguez, A., Hof, A. W. J. V. ’., Müller, P. F., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.032 · Cited by 21
Plakht, Y., Gilutz, H., & Shiyovich, A. (2016) · Public Health · doi:10.1016/j.puhe.2016.09.032 · Cited by 21
“The latter is in coherence with the findings of revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial, reported reduced mortality among CABG-treated patients compared with PCI.33 In contrast to the present analysis, the FREEDOM trial was limited to d…”
ResultInfluentialMilojevic, M., Head, S. J., Mack, M. J., Mohr, F. W., Morice, M., Dawkins, K. D., Holmes, D. R., Serruys, P. W. J. C., & Kappetein, A. P. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx104 · Cited by 21
Self-citationOptimal Medical Therapy for Known Coronary Artery Disease: A Review
Gibbons, R. J., & Miller, T. D. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2249 · Cited by 23
Yang, Y., Park, G., Han, S., Kim, Y., Suh, J., Park, H. W., Won, K., Ann, S. H., Kim, S., Kim, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208746 · Cited by 22
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study.
Holte, K. B., Svanteson, M., Hanssen, K., Haig, Y., Solheim, S., & Berg, T. J. (2019) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2019.01.006 · Cited by 23
Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., Ishii, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0865 · Cited by 26
Shafì, A. M. A., Abuelgasim, E., Abuelgasim, B., Iddawela, S., & Harky, A. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15339 · Cited by 21
“This is due to the ease and speed of use, low cost of wires and the relatively low rate of complications.(3) Moreover, a recent meta‐analysis of seven clinical trials found that newer closure methods, such as used rigid plates, thermoreactive clips and cables, make little or no difference regarding the prevention of s…”
BackgroundAcute coronary syndromes and diabetes mellitus
Foussas, S. G. (2016) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2016.12.012 · Cited by 22
Fall and Rise of Coronary Intervention
Lahoud, R. N., & Dauerman, H. L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016853 · Cited by 21
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.